Catalyst Wire Dossier Catalyst Wire Dossier

rhNGF eye drops

nerve growth factor · Dompé Farmaceutici S.p.A
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rhNGF eye drops, covering 2019-08-07 to 2019-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers [Phase 1]

See pricing